Targeting heparanase-mediated glycocalyx degradation as a novel strategy to inhibit EMT-driven pulmonary fibrosis

International Immunopharmacology 2026

View at publisher
Authors: Shiwang Li, Jie Kang, Haitao Zhang, Yantong Xin, C ZHANG, Song Yang, Xiao Wu
DOI: 10.1016/j.intimp.2026.116977
Cited by: 1
References: 39

Fields of Study & Subjects

Proteoglycans and glycosaminoglycans research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary Hypertension Research and Treatments

Publication details

Journal / source
International Immunopharmacology
Publisher
Elsevier BV
Volume
185
Pages
116977–116977
Publication date
13 June 2026
Language
EN